Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05584007
PHASE3

Cellulitis Optimal Antibiotic Treatment

Sponsor: University of Southampton

View on ClinicalTrials.gov

Summary

To determine whether a short course of oral flucloxacillin (5 days) is non-inferior to a standard course (7 days) in terms of pain over days 6-14 (indicative of persistence or recurrence associated with the symptoms of most importance to patients) in adults with cellulitis of the leg presenting in primary care.

Official title: A Blinded, Non-inferiority Phase III Trial of 5 Versus 7 Days of Oral Flucloxacillin in Primary Care Patients With Lower Limb Cellulitis

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

356

Start Date

2023-08-29

Completion Date

2026-10-01

Last Updated

2024-12-09

Healthy Volunteers

No

Interventions

DRUG

Flucloxacillin Only Product in Oral Dose Form

Patients will be prescribed flucloxacillin 500mg QDS for 5 days followed by blinded flucloxacillin 500mg for 2 days, reaching a total of 7 days of antibiotic treatment

DRUG

Placebo Only Product in Oral Dose Form

Patients will be prescribed flucloxacillin 500mg QDS for 5 days followed by a blinded placebo for 2 days, reaching a total of 5 days of antibiotic treatment

Locations (1)

Royal South Hants Hospital

Southampton, United Kingdom